Nykode Therapeutics board chair increases stake in company

Ubiquity AS, a company wholly owned by Susanne Stuffers, chair of the board and a primary insider at Nykode Therapeutics ASA, has acquired 280,000 shares in the company. The transaction, executed on October 10, 2025, on the Oslo Stock Exchange (XOSL), was performed at an average price of NOK 1.8113 per share, totaling NOK 507,154.92.

Following this acquisition, Susanne Stuffers directly and indirectly holds a total of 296,665 shares in Nykode Therapeutics ASA. This includes the 280,000 shares held through Ubiquity AS, and an additional 16,665 shares held directly.

The acquisition involved multiple transactions at varying prices, ranging from NOK 1.782 to NOK 1.85. This move by a primary insider may signal confidence in the future prospects of Nykode Therapeutics.